Toni Stephenson Lymphoma Center Featured Grant Funding

National Cancer Institute - Lymphoma SPORE ($ 12.5M)

The Leukemia & Lymphoma Society - Mantle Cell Lymphoma SCOR ($ 2.5M) (2018-2022) (L. Kwak)

  • Project 1: A Novel CAR T Cell Therapy Targeting BAFF-R for Mantle Cell Lymphoma (L. Kwak, H. Qin)
  • Project 2: Combining CAR T Cells With Signaling Modulators for Treatment of Relapsed/Refractory Mantle Cell Lymphoma (S. Forman, X. Wang, E. Budde)
  • Project 3: Selective Targeting of Cyclin-dependent Kinase-9 (CDK9) for Treatment of Mantle Cell Lymphoma. (A. Danilov)
  • Core A: Pathology and Tissue Bank Core (J. Chan, J. Song)
  • Core B: Translational Core (S. Thomas, C. Matsumoto)

The Leukemia & Lymphoma Society - Influential Medicine Providing Access to Clinical Trials (IMPACT) Award (2022-2027) 

Establishing Hematology Clinical Trial Hubs Within the City of Hope Community and Affiliate Network (T. Siddiqi) 

National Cancer Institute - R01 grant (2021-2026) 

R01 Overcoming Ibrutinib Resistance in Mantle Cell Lymphoma (A. Danilov) 

National Cancer Institute - R01 grant (2019-2024) 

Cutaneous T cell Lymphoma: A Paradigm for Dissecting Susceptibility and Resistance to Checkpoint Inhibition Therapy (C. Querfeld) 

V Foundation - V Clinical Scholar Program (2021-2023) 

Optimizing Immunotherapy for Hodgkin Lymphoma (A. Herrera) 

The Leukemia & Lymphoma Society - Scholar in Clinical Research Award (2018-2023) 

Unraveling the Mechanisms of Immune Checkpoint Dysfunction in Cutaneous T Cell Lymphoma (C. Querfeld) 

The Leukemia & Lymphoma Society - Scholar in Clinical Research Award (2022-2027) 

Stratified Treatment of Newly Diagnosed Mantle Cell Lymphoma Based on the Presence or Absence of High Risk Features Utilizing Non-cytotoxic Agents (T. Phillips)

National Cancer Institute - R01 Grant (2021-2026) 

BAFF-R CAR T cell therapy for ALL (L. Kwak, X. Wang, I. Aldoss) 

National Cancer Institute - U01 Grant (2021-2026) 

Pre-analytical Variables of Bioanalytes Affecting the Accuracy of PTCL Diagnostic and Prognostic Genetic Signatures (J. Chan, J. Iqbal, M. Murtaza)